Identification of epigenetically active L1 promoters in the human brain and their relationship with psychiatric disorders.


Journal

Neuroscience research
ISSN: 1872-8111
Titre abrégé: Neurosci Res
Pays: Ireland
ID NLM: 8500749

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 02 02 2023
revised: 09 04 2023
accepted: 01 05 2023
medline: 25 8 2023
pubmed: 5 5 2023
entrez: 4 5 2023
Statut: ppublish

Résumé

Long interspersed nuclear element-1 (LINE-1, L1) affects the transcriptome landscape in multiple ways. Promoter activity within its 5'UTR plays a critical role in regulating diverse L1 activities. However, the epigenetic status of L1 promoters in adult brain cells and their relationship with psychiatric disorders remain poorly understood. Here, we examined DNA methylation and hydroxymethylation of the full-length L1s in neurons and nonneurons and identified "epigenetically active" L1s. Notably, some of epigenetically active L1s were retrotransposition competent, which even had chimeric transcripts from the antisense promoters at their 5'UTRs. We also identified differentially methylated L1s in the prefrontal cortices of patients with psychiatric disorders. In nonneurons of bipolar disorder patients, one L1 was significantly hypomethylated and showed an inverse correlation with the expression level of the overlapping gene NREP. Finally, we observed that altered DNA methylation levels of L1 in patients with psychiatric disorders were not affected by the surrounding genomic regions but originated from the L1 sequences. These results suggested that altered epigenetic regulation of the L1 5'UTR in the brain was involved in the pathophysiology of psychiatric disorders.

Identifiants

pubmed: 37141946
pii: S0168-0102(23)00091-3
doi: 10.1016/j.neures.2023.05.001
pii:
doi:

Substances chimiques

5' Untranslated Regions 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

37-51

Informations de copyright

Copyright © 2023 Elsevier Ltd and Japan Neuroscience Society. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Risa Watanabe (R)

Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Yutaka Nakachi (Y)

Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Hikari Matsubara (H)

Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Junko Ueda (J)

Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Takao Ishii (T)

Department of Occupational Therapy, Sapporo Medical University School of Health Sciences, Sapporo, Japan.

Wataru Ukai (W)

Department of Neuropsychiatry, Sapporo Medical University, School of Medicine, Sapporo, Japan.

Eri Hashimoto (E)

Department of Neuropsychiatry, Sapporo Medical University, School of Medicine, Sapporo, Japan.

Kiyoto Kasai (K)

Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; The International Research Center for Neurointelligence (WPI-IRCN), University of Tokyo Institutes for Advanced Study (UTIAS), The University of Tokyo, Tokyo, Japan; University of Tokyo Institute for Diversity and Adaptation of Human Mind (UTIDAHM), The University of Tokyo, Tokyo, Japan; UTokyo Center for Integrative Science of Human Behaviour (CiSHuB), The University of Tokyo, Tokyo, Japan.

Siro Simizu (S)

Department of Applied Chemistry, Faculty of Science and Technology, Keio University, Yokohama, Japan.

Tadafumi Kato (T)

Department of Psychiatry and Behavioral Science, Juntendo University Graduate School of Medicine, Tokyo, Japan; Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute, Wako, Saitama, Japan.

Miki Bundo (M)

Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute, Wako, Saitama, Japan. Electronic address: bundo@kumamoto-u.ac.jp.

Kazuya Iwamoto (K)

Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute, Wako, Saitama, Japan. Electronic address: iwamotok@kumamoto-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH